Cormedix Inc (CRMD)
4.49
-0.23
(-4.87%)
USD |
NASDAQ |
Jun 17, 16:00
4.49
0.00 (0.00%)
After-Hours: 20:00
Cormedix Revenue (Annual)
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.0654M |
| December 31, 2021 | 0.1909M |
| December 31, 2020 | 0.2392M |
| December 31, 2019 | 0.2833M |
| December 31, 2018 | 0.4298M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.3293M |
| December 31, 2016 | 0.2241M |
| December 31, 2015 | 0.2101M |
| December 31, 2014 | 0.1893M |
| December 31, 2013 | 0.002M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.0654M
Minimum
2022
0.2833M
Maximum
2019
0.1947M
Average
0.2151M
Median
Revenue (Annual) Benchmarks
| ACADIA Pharmaceuticals Inc | 726.44M |
| Cassava Sciences Inc | -- |
| Vertex Pharmaceuticals Inc | 9.869B |
| Regulus Therapeutics Inc | -- |
| Oragenics Inc | -- |